This is the authors' abstract. We don't add key points for this paper.
Alkyl steroidal AZT 5′-monophosphate triesters are designed as lipophilic prodrugs of AZT to improve its therapeutic efficiency. We have synthesized four phosphotriesters of AZT, in one-pot, using phosphoramidite-phosphite triester methodology. This method afforded the desired prodrugs in high yields under mild conditions. The in vitro evaluation of anti-HIV activity of these prodrugs is also reported.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
BALAGOPALA et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: